AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Study sponsor: Cytokinetics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-09Estimated
Enrollment · participants60Estimated
Source updated2026-08-27Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.